Kaunas, Lithuania, 2011-08-19 11:46 CEST (GLOBE NEWSWIRE) -- On 19 August 2011 Sanitas, AB received the notification of Valeant Pharmaceuticals International, Inc. on the acquisition of voting rights. The threshold that was crossed – 75%, the reason for crossing the threshold – acquisition of shares granting voting rights.
Enclosed: Notification on the acquisition of voting rights.
This notification is also available on AB Sanitas’ website: www.sanitasgroup.com
A person authorized to provide additional information: Mr. Saulius Jurgelenas, Chief Executive Officer of Sanitas, AB phone number +370 686 67779.
Lawyer
Dovile Morkyte
+370 615 15163